Business Context and Reporting Period
This Form 8-K was filed by Vector Acquisition Corporation on March 1, 2021, concerning its proposed business combination with Rocket Lab USA, Inc. The filing is a transaction announcement rather than a periodic financial report and does not provide current-period operating or financial results for Rocket Lab.
Transaction and Key Financial Terms
- Vector, Rocket Lab and Prestige USA Merger Sub, Inc. entered into a definitive Agreement and Plan of Merger.
- The transaction contemplates Vector’s domestication as a Delaware corporation, followed by two mergers resulting in Rocket Lab becoming a wholly owned subsidiary of the surviving public company, referred to as Pubco.
- The transaction implies a Rocket Lab equity value of approximately $4.0 billion, reduced by the amount of specified management redemptions.
- Rocket Lab management may redeem shares for an aggregate amount not exceeding $40 million immediately before closing.
- PIPE investors agreed to purchase 46.7 million Pubco shares at $10.00 per share, generating aggregate gross proceeds of $467 million.
- Rocket Lab’s closing condition requires cash from Vector’s trust account and the PIPE financing, after shareholder redemptions but before transaction costs, to total at least $500 million.
- Vector shareholders will have redemption rights for all or a portion of their Class A shares in connection with the transaction.
- No revenue, profit, cash flow, margin, debt, liquidity balance, or other operating metrics are reported in the filing.
Material Changes Versus the Prior Comparable Period
The filing does not present comparable-period financial statements or operating results. The principal material change is the execution of the proposed business combination and related financing arrangements.
- Rocket Lab and Vector expect the transaction to close in the second quarter of 2021, subject to customary conditions.
- Rocket Lab stockholders representing the requisite approval votes entered into support agreements.
- Vector’s sponsor agreed to vote in favor of the transaction and waive anti-dilution protection for its Class B shares.
- Specified Rocket Lab stockholders will be subject to a six-month post-closing lock-up; the sponsor will be subject to separate transfer restrictions.
Guidance, Outlook, Risks, and Unusual Items
- If Pubco’s closing price reaches at least $20.00 for 20 of 30 consecutive trading days during the applicable period beginning 90 days after closing, Rocket Lab stockholders may receive additional shares equal to 8% of the Aggregate Share Consideration.
- Rocket Lab announced plans for a new 8-ton reusable rocket, but the filing text does not provide a complete financial outlook or quantified operating guidance for that program.
- Closing conditions include regulatory clearance under the HSR Act, approval by Vector shareholders and Rocket Lab stockholders, effectiveness of a Form S-4 registration statement, and satisfaction of other customary representations, covenants and material-adverse-effect conditions.
- Either party may generally terminate the agreement if the transaction has not closed by November 30, 2021, subject to specified exceptions, or if required shareholder approvals are not obtained.
- Key risks include failure to complete the transaction, shareholder redemptions, insufficient financing, regulatory or registration delays, disruption to Rocket Lab’s operations and relationships, competitive and regulatory changes, execution risk, and downturns in the commercial launch, satellite and spacecraft industries.
- The PIPE securities are intended to be issued in an unregistered private placement under Section 4(a)(2) and/or Regulation D.
Investor Verification Checklist
- Review the definitive merger agreement, including the exchange-ratio formula, closing conditions, termination rights and omitted schedules.
- Verify the amount remaining in Vector’s trust account and the effect of potential shareholder redemptions on the required minimum cash condition.
- Confirm whether the $467 million PIPE financing closes and review investor registration rights and any subsequent amendments.
- Review the Form S-4 and proxy statement/prospectus for pro forma ownership, dilution, management incentives, projections and risk factors.
- Assess the terms and potential dilution associated with the management redemption, warrants, options, restricted stock units and contingent additional-share issuance.
- Verify regulatory approvals, shareholder votes and the actual closing date before relying on the proposed transaction structure or valuation.